Promising preliminary results were achieved in 29 evaluable adults with R/R B-ALL who received 2 × 105, 2 × 106, or 2 × 107 CAR-T cells/kg in a defined 1:1 ration of CD4:CD8 composition. This evidence concerns the gene CD8A and acute lymphoblastic leukemia.